An unexpected cause of chest pain, dyspnea and palpitations in a young patient during a post-COVID syndrome

Submitted: August 22, 2022
Accepted: November 3, 2022
Published: November 14, 2022
Abstract Views: 842
PDF: 132
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


A 31-year-old male presented with sudden onset of chest pain and dyspnea after a COVID-19 infection. Initially labeled as a myopericarditis related to COVID-19, because of the young age and low risk profile, after a multiparametric evaluation was possible to diagnose and treat an unstable lesion on an intermediate branch of left coronary.



PlumX Metrics


Download data is not yet available.


Kapoor MC. Respiratory and cardiovascular effects of COVID-19 infection and their management. J Anaesthesiol Clin Pharmacol 2020;36:S21-8. DOI:
Joly BS, Siguret V, Veyradier A. Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19. Intensive Care Med 2020;46:1603-6. DOI:
Hamilton MA, Toner A, Cecconi M. Troponin in critically ill patients. Minerva Anestesiol 2012;78:1039-45.
Guglin M, Ballut K, Ilonze O, et al. Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 2020. Heart Fail Rev 2022;27:1341-53. DOI:
Toscano O, Cosentino N, Campodonico J, et al. Acute myocardial infarction during the COVID-19 pandemic: An update on clinical characteristics and outcomes. Front Cardiovasc Med 2021;8:648290. DOI:
Long X, Zhang Z, Zou W, et al. Coagulopathy of patients with COVID-19 is associated with infectious and inflammatory markers. Risk Manag Healthc Policy 2020;13:1965-75. DOI:
Saed Aldien A, Ganesan GS, Wahbeh F, et al. Systemic inflammation may induce cardiac injury in COVID-19 Patients including children and adolescents without underlying cardiovascular diseases: A systematic review. Cardiovasc Revasc Med 2022;35:169-78. DOI:
Schiavone M, Gobbi C, Biondi-Zoccai G, et al. Acute coronary syndromes and Covid-19: Exploring the uncertainties. J Clin Med 2020;9:1683. DOI:
Zhu H, Zhang L, Ma Y, et al. The role of SARS-CoV-2 target ACE2 in cardiovascular diseases. J Cell Mol Med 2021;25:1342-9. DOI:
Ni W, Yang X, Yang D, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care 2020;24:422. DOI:
Lei Y, Zhang J, Schiavon CR, et al. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Circ Res 2021;128:1323-6. DOI:
Kwong JC, Schwartz KL, Campitelli MA, et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med 2018;378:345-53. DOI:
Castiello T, Georgiopoulos G, Finocchiaro G, et al. COVID-19 and myocarditis: a systematic review and overview of current challenges. Heart Fail Rev 2022;27:251-61. DOI:
Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood 2020;135:2033-40. DOI:
Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med 2021;27:601-15. DOI:

How to Cite

Cacciapuoti, Fulvio, Ilaria Caso, Mario Crisci, Fabio Minicucci, and Federico Cacciapuoti. 2022. “An Unexpected Cause of Chest Pain, Dyspnea and Palpitations in a Young Patient During a Post-COVID Syndrome”. Monaldi Archives for Chest Disease 93 (3).